Capital · venture → company
UVA Licensing & Ventures Group
The only path from a UVA lab notebook to a company.
41IP deals completed
6new ventures launched
60+active companies
Overview
A 501(c)(3) founded in 1977 and wholly aligned to UVA, the Licensing & Ventures Group handles every startup built on UVA intellectual property. Its portfolio includes Hyku Biosciences, launched with $56M, and Advaray, acquired by CQ Medical.
- 79 patent applications filed this year
- 60+ active companies nationwide advancing UVA discoveries
- Portfolio includes Contraline, Laser Thermal, KeViRx, BrightSpec, AgroSpheres, Adial
- Signed Virginia’s Lab-to-Launch initiative, 2025
- Adopting the Commonwealth’s first standardized Fast-Track License
In the news
All storiesFaculty founder · February 2026
A conversation with faculty founder Silvia Salinas BlemkerThe Professor of Biomedical Engineering is CSO and co-founder of Springbok Analytics.
Commonwealth · February 2026
Lab-to-Launch gives faculty an “easy button” for startupsStandardized terms and $50,000 in commercialization funding for UVA faculty founders.
Connected across the map
CapitalLVG Seed I & II$20M · 2 exitsTranslationEnterprise Studio115 venturesThe CommonwealthLab-to-Launch6 R1s · fast-trackSpeed & ScaleCODE Building215K sq ft downtownTranslationCoulter Center25 startups · $1.4BThe SchoolsLawE-ship Clinic · IP CenterTranslationCorporate Partnersevery school has themSpeed & ScaleCommonwealth BioAccelerator$15M+ · 6 venturesSpeed & ScaleIX Park2 UVA spinouts